According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy (IMRT) as part of chemoradiation treatment for patients with oropharyngeal (head and neck) cancer.
New Initiative Examines Misuse of Race in Medical Research
What You Should Know: Doris Duke Foundation (DDF) announce the launch of Racial Equity in Clinical Equations, a new initiative to examine the misuse of
June 28, 2023